NCT01397084View on ClinicalTrials.gov

To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

PHASE4CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Gastroesophageal Reflux DiseaseGERDReflux Esophagitis
Interventions
DRUG

esomeprazole 20 mg

esomeprazole 20 mg once daily for 8 weeks

Sponsors

Lead Sponsor

AstraZeneca

Collaborators (1)

Parexel
All Listed Sponsors
collaborator

Parexel

INDUSTRY

lead

AstraZeneca

INDUSTRY